Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

NCT07104812 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07104812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07104812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
January 14, 2026
Completion date
January 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autonomous cortisol secretion (acs), mild autonomous cortisol secretion